FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145438333> ?p ?o ?g. }

• W2145438333 endingPage "244" @default.
• W2145438333 startingPage "234" @default.
• W2145438333 abstract "Oral bisphosphonates (BPs) are highly effective in preventing fractures and are recommended first-line therapies for patients with osteoporosis. We identified the incidence and predictors of oral BP treatment failure, defined as the incidence of two or more fractures while on treatment (≥2 FWOT) among users with high adherence. Fractures were considered from 6 months after treatment initiation and up to 6 months after discontinuation. Data from computerized records and pharmacy invoices were obtained from Sistema d‘Informació per al Desenvolupament de l‘Investigació en Atenció Primària (SIDIAP; Catalonia, Spain) and Danish Health Registries (Denmark) for all incident users of oral BPs in 2006-2007 and 2000-2001, respectively. Fine and Gray survival models using backward-stepwise selection (p-entry 0.049; p- exit 0.10) and accounting for the competing risk of therapy cessation were used to identify predictors of ≥2 FWOT among patients having persisted with treatment ≥6 months with overall medication possession ratio (MPR) ≥80%. Incidence of ≥2 FWOT was 2.4 (95% confidence interval [CI], 1.8 to 3.2) and 1.7 (95% CI, 1.2 to 2.2) per 1000 patient-years (PYs) within Catalonia and Denmark, respectively. Older age was predictive of ≥2 FWOT in both Catalonian and Danish cohorts: subhazard ratio (SHR) = 2.28 (95% CI, 1.11 to 4.68) and SHR = 2.61 (95% CI, 0.98 to 6.95), respectively, for 65 to <80 years; and SHR = 3.19 (95% CI, 1.33 to 7.69) and SHR = 4.88 (95% CI, 1.74 to 13.7), respectively, for ≥80 years. Further significant predictors of ≥2 FWOT identified within only one cohort were dementia, SHR = 4.46 (95% CI, 1.02 to 19.4) (SIDIAP); and history of recent or older fracture, SHR = 3.40 (95% CI, 1.50 to 7.68) and SHR = 2.08 (95% CI: 1.04-4.15), respectively (Denmark). Even among highly adherent users of oral BP therapy, a minority sustain multiple fractures while on treatment. Older age was predictive of increased risk within both study populations, as was history of recent/old fracture and dementia within one but not both populations. Additional and/or alternative strategies should be investigated for these patients. © 2015 American Society for Bone and Mineral Research." @default.
• W2145438333 created "2016-06-24" @default.
• W2145438333 creator A5002628934 @default.
• W2145438333 creator A5006787435 @default.
• W2145438333 creator A5026948399 @default.
• W2145438333 creator A5030613053 @default.
• W2145438333 creator A5032591631 @default.
• W2145438333 creator A5049564443 @default.
• W2145438333 creator A5058622525 @default.
• W2145438333 creator A5064307236 @default.
• W2145438333 creator A5064914075 @default.
• W2145438333 creator A5067438197 @default.
• W2145438333 creator A5086010333 @default.
• W2145438333 date "2016-01-01" @default.
• W2145438333 modified "2023-10-08" @default.
• W2145438333 title "Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study" @default.
• W2145438333 cites W1593442063 @default.
• W2145438333 cites W1596108036 @default.
• W2145438333 cites W1858127434 @default.
• W2145438333 cites W1967626536 @default.
• W2145438333 cites W1968717221 @default.
• W2145438333 cites W1970974790 @default.
• W2145438333 cites W1985327136 @default.
• W2145438333 cites W1993035292 @default.
• W2145438333 cites W2001234857 @default.
• W2145438333 cites W2005298224 @default.
• W2145438333 cites W2007812917 @default.
• W2145438333 cites W2009565603 @default.
• W2145438333 cites W2015718770 @default.
• W2145438333 cites W2026820851 @default.
• W2145438333 cites W2038981426 @default.
• W2145438333 cites W2062803178 @default.
• W2145438333 cites W2065404058 @default.
• W2145438333 cites W2067546919 @default.
• W2145438333 cites W2068543989 @default.
• W2145438333 cites W2070531118 @default.
• W2145438333 cites W2075793631 @default.
• W2145438333 cites W2080063171 @default.
• W2145438333 cites W2081963513 @default.
• W2145438333 cites W2082158800 @default.
• W2145438333 cites W2082466238 @default.
• W2145438333 cites W2097028060 @default.
• W2145438333 cites W2107177524 @default.
• W2145438333 cites W2110396808 @default.
• W2145438333 cites W2111000907 @default.
• W2145438333 cites W2124527463 @default.
• W2145438333 cites W2127961450 @default.
• W2145438333 cites W2139062201 @default.
• W2145438333 cites W2153009489 @default.
• W2145438333 cites W2163830908 @default.
• W2145438333 cites W4240851819 @default.
• W2145438333 doi "https://doi.org/10.1002/jbmr.2595" @default.
• W2145438333 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26174968" @default.
• W2145438333 hasPublicationYear "2016" @default.
• W2145438333 type Work @default.
• W2145438333 sameAs 2145438333 @default.
• W2145438333 citedByCount "15" @default.
• W2145438333 countsByYear W21454383332016 @default.
• W2145438333 countsByYear W21454383332017 @default.
• W2145438333 countsByYear W21454383332018 @default.
• W2145438333 countsByYear W21454383332019 @default.
• W2145438333 countsByYear W21454383332020 @default.
• W2145438333 countsByYear W21454383332022 @default.
• W2145438333 countsByYear W21454383332023 @default.
• W2145438333 crossrefType "journal-article" @default.
• W2145438333 hasAuthorship W2145438333A5002628934 @default.
• W2145438333 hasAuthorship W2145438333A5006787435 @default.
• W2145438333 hasAuthorship W2145438333A5026948399 @default.
• W2145438333 hasAuthorship W2145438333A5030613053 @default.
• W2145438333 hasAuthorship W2145438333A5032591631 @default.
• W2145438333 hasAuthorship W2145438333A5049564443 @default.
• W2145438333 hasAuthorship W2145438333A5058622525 @default.
• W2145438333 hasAuthorship W2145438333A5064307236 @default.
• W2145438333 hasAuthorship W2145438333A5064914075 @default.
• W2145438333 hasAuthorship W2145438333A5067438197 @default.
• W2145438333 hasAuthorship W2145438333A5086010333 @default.
• W2145438333 hasBestOaLocation W21454383331 @default.
• W2145438333 hasConcept C120665830 @default.
• W2145438333 hasConcept C121332964 @default.
• W2145438333 hasConcept C126322002 @default.
• W2145438333 hasConcept C138885662 @default.
• W2145438333 hasConcept C164622146 @default.
• W2145438333 hasConcept C187212893 @default.
• W2145438333 hasConcept C207103383 @default.
• W2145438333 hasConcept C2776541429 @default.
• W2145438333 hasConcept C2778715236 @default.
• W2145438333 hasConcept C2908647359 @default.
• W2145438333 hasConcept C41895202 @default.
• W2145438333 hasConcept C44249647 @default.
• W2145438333 hasConcept C61511704 @default.
• W2145438333 hasConcept C71924100 @default.
• W2145438333 hasConcept C72563966 @default.
• W2145438333 hasConcept C99454951 @default.
• W2145438333 hasConceptScore W2145438333C120665830 @default.
• W2145438333 hasConceptScore W2145438333C121332964 @default.
• W2145438333 hasConceptScore W2145438333C126322002 @default.
• W2145438333 hasConceptScore W2145438333C138885662 @default.
• W2145438333 hasConceptScore W2145438333C164622146 @default.

• next